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The scaffold protein CNK1 was described to be involved
in protooncogenic signalling pathways utilising protein
kinases Raf-1 and Src and the small GTPase Rho. Deregu-
lation of these molecules is clearly correlated with cancer.
Nonetheless, a direct impact of CNK1 on cancer cell
behaviour was not investigated so far. To address this
question we analysed the function of CNK1 in a highly
invasive breast cancer cell line MDA-MB-231.
Downregulation of CNK1 by retroviral shRNA delivery
reduced cell proliferation and this effect was even more
pronounced under serum starvation. Furthermore, knock-
down of CNK1 impaired the invasion of Matrigel by
MDA-MB-231 cells without affecting cell migration, sug-
gesting a defect in proteolytic activity in these cells. In
agreement with this observation, expression of several
matrix metalloproteinases was diminished in CNK1
knockdown cells. In particular the promoter of membrane
type 1 matrix metalloproteinase (MT1-MMP) was shown
to by less active upon CNK1 downregulation. Conversely,
CNK1 overexpression stimulated the MT1-MMP pro-
moter. This stimulatory effect was sensitive to the IKK
inhibitor BAY11-7082 and the PI3K inhibitor LY294002.
CNK1 was found to influence the alternative NF-κB path-
way through regulation of the processing step from p100
to p52. Moreover, phosphorylation of Akt on Ser 473 was
reduced in CNK1 knockdown cells, a result which is con-
sistent with Akt's importance in p100 processing. Impor-
tantly, analysis of human cancer samples by
immunohistochemistry revealed that CNK1 can be over-
expressed in breast cancer samples compared to healthy
tissue.
Taken together, these results provide evidence that CNK1
is a part of the invasion-promoting machinery in breast
cancer cells and may be considered as a potential thera-
peutic target.
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